Coexisting Abnormal Esophageal Body Motility Predicts Clinical Symptoms and Bolus Transit in Patients With Esophagogastric Junction Outflow Obstruction (EGJOO). Issue 6 (July 2021)

• Record Type: Journal Article
• Authors: Jodorkovsky, Daniela; Wong, Danny; Din, Ryan; Sikavi, Daniel R.; Lee, Darren J.H.; Cai, Jennifer X.; Lo, Wai-Kit; Chan, Walter W.
• Is Part Of: Journal of clinical gastroenterology. Volume 55:Issue 6(2021)
• Publication Date: 2021-07
• Subjects: esophagogastric junction outflow obstruction -- esophageal motility disorders -- ineffective esophageal motility -- hypercontractile esophagus; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Digestive organs -- Diseases; Gastroenterology; Periodicals; Periodicals; 616.33005
• DOI: 10.1097/MCG.0000000000001390
• Languages: English
• ISSNs: 0192-0790

Abstract

Abstract : Goal: The goal of this study was to compare the clinical presentations of esophagogastric junction outflow obstruction (EGJOO) with coexisting abnormal esophageal body motility (EBM) to isolated EGJOO. Background: The clinical significance and management of EGJOO remain debated, as patients may have varied to no symptoms. The effect of coexisting abnormal EBM in EGJOO is unclear. We hypothesized that a concomitant EBM disorder is associated with clinical symptoms of EGJOO. Study: This was a retrospective cohort study of consecutive adults diagnosed with EGJOO on high-resolution impedance-manometry (HRIM) at 2 academic centers in March 2018 to September 2018. Patients with prior treatment for achalasia, foregut surgery, or evidence of obstruction were excluded. Subjects were divided into EGJOO with abnormal EBM per Chicago classification v3.0 and isolated EGJOO. Statistical analyses were performed using Fisher-exact or Student t test (univariate) and logistic or linear regression (multivariate). Results: Eighty-two patients (72% women, age 61.1±10.7 y) were included. Thirty-one (37.8%) had abnormal EBM, including 16 (19.5%) ineffective esophageal motility and 15 (18.2%) hypercontractile esophagus. Esophageal symptoms (heartburn, regurgitation, chest pain, dysphagia) were more prevalent among those with abnormal EBM (90.3% vs. 64.7%, P =0.01). On logistic regression adjusting for age, gender, body mass index, and opioid use, abnormal EBM remained predictive of esophageal symptoms (adjusted odds ratio [aOR] 7.51, P =0.007). On separate models constructed, HE was associated with chest pain (aOR 7.45, P =0.01) and regurgitation (aOR 4.06, P =0.046), while ineffective esophageal motility was predictive of heartburn (aOR 5.84, P =0.009) and decreased complete bolus transit (β-coefficient −0.177, P =0.04). Conclusion: Coexisting abnormal EBM is associated with esophageal symptoms and bolus transit in patients with EGJOO.